BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BIOA BioAge Labs Inc.

Market Closed 05-29 16:00:00 EDT

17.29

+0.24

+1.41%

盘后17.29

+0.000.00%

19:16 EDT

High17.30	Low16.80	Vol234.16K
Open17.00	D1 Closing17.05	Amplitude2.93%
Mkt Cap767.33M	Tradable Cap494.07M	Total Shares44.38M
T/O4.01M	T/O Rate0.82%	Tradable Shares28.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":17.29,"timestamp":1780084800000,"preClose":17.05,"halted":0,"volume":234162,"hourTrading":{"tag":"盘后","latestPrice":17.29,"preClose":17.29,"latestTime":"19:16 EDT","volume":14105,"amount":243875.77,"timestamp":1780096582243,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014076246334310758,"floatShares":28575500,"shares":44379800,"eps":-2.392358,"marketStatus":"Market Closed","change":0.24,"latestTime":"05-29 16:00:00 EDT","open":17,"high":17.3,"low":16.8,"amount":4012781.741712,"amplitude":0.029326,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.392358,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":17.05,"preHourTrading":{"tag":"盘前","latestPrice":16.55,"preClose":17.05,"latestTime":"08:49 EDT","volume":594,"amount":9915.120468000001,"timestamp":1780058956404,"change":-0.5,"changeRate":-0.029326,"amplitude":0.069795},"postHourTrading":{"tag":"盘后","latestPrice":17.29,"preClose":17.29,"latestTime":"19:16 EDT","volume":14105,"amount":243875.77,"timestamp":1780096582243,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4264062044653463,"impliedVol":0.7934,"impliedVolPercentile":0.4661},"requestUrl":"/m/hq/s/BIOA","defaultTab":"news","newsList":[{"id":"2638501627","title":"Roth Capital Partners Initiates BioAge Labs at Buy With $36 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638501627","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638501627?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:41","pubTimestamp":1779878494,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) has an average rating of buy and mean price target of $49.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638509976","title":"BioAge Labs Initiated at Buy by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638509976","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638509976?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:18","pubTimestamp":1779877080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 06:18 ET (10:18 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638570432","title":"BioAge Labs initiated with a Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638570432","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638570432?lang=en_us&edition=fundamental","pubTime":"2026-05-27 16:20","pubTimestamp":1779870008,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Adam Walsh initiated coverage of BioAge Labs (BIOA) with a Buy rating and $36 price target The firm believes the company’s lea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314726","title":"BioAge Labs joins Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314726","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637314726?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:00","pubTimestamp":1779454857,"startTime":"0","endTime":"0","summary":"BioAge Labs will attend the Jefferies Global Healthcare Conference in New York on June 3-4, 2026.A fireside chat is scheduled for June 4, 2026, from 3:45-4:15 p.m. EDT.The company will also attend the Goldman Sachs Global Healthcare Conference in Miami Beach on June 8-10, 2025, with a fireside chat set for June 8, 2025, from 2:40-3:15 p.m. EDT.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLcclySm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","BK4112","IE00BSNM7G36.USD","BK4552","IE0002270589.USD","IE00B19Z3581.USD","LU0942090050.USD","LU2237443549.SGD","LU2237443978.SGD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU1868836591.USD","BK4127","LU2750360641.GBP","IE00B64PRP62.GBP","LU0314104364.USD","LU1804176565.USD","LU1868836757.USD","LU2237438978.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","GSX","LU2095319765.USD","NDAQ","LU2237443622.USD","BK4007","IE0004086264.USD","IE00BKPKM429.USD","LU0251131958.USD","LU0345770993.USD","LU2750360997.AUD","LU1668664300.SGD","LU2471134796.USD","LU0106831901.USD","LU2471134879.HKD","LU2210150020.SGD","IE00BGHQF748.EUR","LU1791807156.HKD","LU1868837300.USD","LU1894683264.USD","LU2210149790.SGD","LU1894683348.USD","IE0004091025.USD","IE00BN0W2V16.EUR","LU2265009873.SGD","LU0345770308.USD","LU0868494708.USD","LU1868837136.USD","LU0742534661.SGD","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312872","title":"BioAge Labs to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312872","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637312872?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:00","pubTimestamp":1779454800,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., May  22, 2026  (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) (\"BioAge\", \"the Company\"), a clinical-stage biotechnology company developing therapeutic product candidates for ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300131/0/en/BioAge-Labs-to-Present-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786774","title":"BTIG Initiates BioAge Labs at Buy With $40 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786774","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786774?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:13","pubTimestamp":1778670802,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) has an average rating of overweight and mean price target of $51.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635368783","title":"BioAge Labs Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2635368783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635368783?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:26","pubTimestamp":1778667960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2026 06:26 ET (10:26 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635200797","title":"BioAge Labs initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2635200797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635200797?lang=en_us&edition=fundamental","pubTime":"2026-05-13 17:55","pubTimestamp":1778666109,"startTime":"0","endTime":"0","summary":"BTIG initiated coverage of BioAge Labs (BIOA) with a Buy rating and $40 price target BioAge is a clinical-stage biopharmaceutical company focused o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213137","title":"Earnings Beat: BioAge Labs, Inc. (NASDAQ:BIOA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213137","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213137?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:37","pubTimestamp":1778582225,"startTime":"0","endTime":"0","summary":"A week ago, BioAge Labs, Inc. ( NASDAQ:BIOA ) came out with a strong set of first-quarter numbers that could...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/earnings-beat-bioage-labs-inc-nasdaqbioa-just-beat-analyst-f","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/earnings-beat-bioage-labs-inc-nasdaqbioa-just-beat-analyst-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634313802","title":"Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634313802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634313802?lang=en_us&edition=fundamental","pubTime":"2026-05-12 02:20","pubTimestamp":1778523612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4581","BK4585","BK4139","LU0029874061.USD","XLV","HCSG","LXEO","BK4588","BIOA","XBI","LABU","LU0128526141.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634236426","title":"BioAge Labs posts R&D Day presentation on BGE-102 program","url":"https://stock-news.laohu8.com/highlight/detail?id=2634236426","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634236426?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:10","pubTimestamp":1778519453,"startTime":"0","endTime":"0","summary":"BioAge Labs published an R&D Day presentation highlighting Phase 1 results for lead program BGE-102, an oral brain-penetrant NLRP3 inhibitor positioned for cardiometabolic disease.Presentation flagged 86% hsCRP reduction in obese subjects, with 87-93% achieving normalized hsCRP below 2 mg/L.Program profile included 24-hour IL-1β suppression of at least 90% at 60 mg once daily, with CNS penetration reported at about 0.7 Kp,uu CSF at 120 mg multiple ascending dose on day 14.Update outlined upcoming proof-of-concept readouts for cardiovascular risk in H2 2026, with diabetic macular edema proof-of-concept targeted for mid-2027.Company also highlighted an APJ agonist obesity program, with IND submission targeted for year-end 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL2rQJhj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634020034","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2634020034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634020034?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·ATL Braves C                                   1Q      (.78)   8:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","ACHV","BETA","CEG","BATRK","CHRS","CLLS","CINT","CLSK","BCAX","CGBD","ATRO","BATRA","AEYE","ACRS","AMBQ","BCSF","ACH","APC","AIP","B","CRCL","BTAI","ACET","APEI","BGS","DCGO","ARMK","ABCL","CDRE","CBLL","ACM","ARVN","ANDG","ACXP","ASTS","BALY","CEVA","COOK","BRCB","ABOS","AMTM","CVRX","CERT","BLNK","AGNT","ALGS","ASRT","ALLT","BODI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634440448","title":"Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634440448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634440448?lang=en_us&edition=fundamental","pubTime":"2026-05-10 21:50","pubTimestamp":1778421041,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-bioage-labs-inc-bioa-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-bioage-labs-inc-bioa-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4581","BK4585","LU0029874061.USD","XLV","AMLX","HCSG","BK4588","BIOA","XBI","LABU","LU0128526141.USD","PHVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633092450","title":"BioAge Labs reports Q1 EPS (52c), consensus (63c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633092450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633092450?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:21","pubTimestamp":1778253689,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $2.77M, consensus $1.08M. “The positive topline Phase 1 data we reported for BGE-102 in April reinforce our conviction that we h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-reports-q1-eps-52c-consensus-63c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-reports-q1-eps-52c-consensus-63c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143337615","title":"BioAge Labs Reports Q1 GAAP Loss of $0.52 Per Share on $2.8 Million Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1143337615","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143337615?lang=en_us&edition=fundamental","pubTime":"2026-05-08 22:51","pubTimestamp":1778251918,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company BioAge Labs Inc. has announced its financial results for the first quarter of 2026, reporting a GAAP loss per share of $0.52 and revenue of $2.8 million. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007","UDN","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633454636","title":"BioAge Labs Q1 Loss Widens, Collaboration Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2633454636","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633454636?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:29","pubTimestamp":1778246953,"startTime":"0","endTime":"0","summary":"BioAge Labs  reported a Q1 loss Friday of $0.52 per diluted share, wider than a loss of $0.36 a year earlier.Analysts polled by FactSet expected a loss of $0.64.Collaboration revenue for the quarter ended March 31 was $2.8 million, up from $1.5 million a year earlier.Analysts surveyed by FactSet expected $1.1 million.BioAge said that as of March 31 it had about $384.9 million in cash, cash equivalents, and marketable securities, which it expects to be enough to fund operations through 2029.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633645198","title":"Bioage Labs Q1 EPS $(0.52) Beats $(0.64) Estimate, Sales $2.772M Beat $1.083M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633645198","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633645198?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:09","pubTimestamp":1778245796,"startTime":"0","endTime":"0","summary":"Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.64) by 18.75 percent. This is a 44.44 percent decrease over losses of $(0.36) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52407662/bioage-labs-q1-eps-0-52-beats-0-64-estimate-sales-2-772m-beat-1-083m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633961451","title":"BioAge Labs Q1 collaboration revenue beats estimates on Novartis collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2633961451","media":"Reuters","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633961451?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:09","pubTimestamp":1778245783,"startTime":"0","endTime":"0","summary":"BioAge Labs Q1 collaboration revenue beats estimates on Novartis collaborationOverviewUS biopharma firm's Q1 collaboration revenue rose, beating analyst expectationsNet loss widened on higher R&D expe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL1N41L0K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633714459","title":"Bioage Labs Inc Q1 Collaboration Revenue USD 2.772 Million VS. Ibes Estimate USD 1.32 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633714459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633714459?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nPLXA6847F:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459717","title":"Bioage Labs Inc Q1 EPS USD -0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633459717?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nPLXA6847F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://bioagelabs.com","stockEarnings":[{"period":"1week","weight":0.0409},{"period":"1month","weight":0.0255},{"period":"3month","weight":-0.2236},{"period":"6month","weight":0.8219},{"period":"1year","weight":3.3442},{"period":"ytd","weight":0.3069}],"compareEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.0631},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.107},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.1093}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":" ","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.008123},{"month":2,"riseRate":0.4,"avgChangeRate":-0.16094},{"month":3,"riseRate":0.2,"avgChangeRate":-0.091972},{"month":4,"riseRate":0.4,"avgChangeRate":-0.044244},{"month":5,"riseRate":0,"avgChangeRate":-0.19738},{"month":6,"riseRate":0.25,"avgChangeRate":0.003055},{"month":7,"riseRate":0.4,"avgChangeRate":-0.005696},{"month":8,"riseRate":0.4,"avgChangeRate":-0.229124},{"month":9,"riseRate":0.6,"avgChangeRate":0.004924},{"month":10,"riseRate":0.8,"avgChangeRate":0.181962},{"month":11,"riseRate":0.6,"avgChangeRate":0.056827},{"month":12,"riseRate":0.2,"avgChangeRate":-0.087267}],"exchange":"NASDAQ","name":"BioAge Labs Inc.","nameEN":"BioAge Labs Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioAge Labs Inc.(BIOA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioAge Labs Inc.,BIOA,BioAge Labs Inc.股票,BioAge Labs Inc.股票老虎,BioAge Labs Inc.股票老虎国际,BioAge Labs Inc.行情,BioAge Labs Inc.股票行情,BioAge Labs Inc.股价,BioAge Labs Inc.股市,BioAge Labs Inc.股票价格,BioAge Labs Inc.股票交易,BioAge Labs Inc.股票购买,BioAge Labs Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioAge Labs Inc.(BIOA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}